Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

Healthcare and medical manufacturing in Australia is gaining momentum with ASX companies at the forefront of growth.

Pfizer delayed the announcement of its COVID-19 vaccine until after the 2020 election when it thought Donald Trump was ...

Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Key Takeaways Moderna and other vaccine stocks fell Monday after the Food and Drug Administration's vaccine chief, Peter ...

Shares of vaccine companies dropped after the Food and Drug Administration's top vaccine official was pushed out in a clash with Health and Human Services Secretary Robert F. Kennedy Jr.

This is the second of two parts about the fifth anniversary since the COVID-19 pandemic began. Dr. James Goldberg, chief medical officer for Providence St. Joseph Hospital in ...

Dr. Peter Marks, a veteran of the agency, wrote that undermining confidence in vaccines is irresponsible and a danger to ...

Dr. Patrick Soon-Shiong said of rising cancer rates and COVID "it's not a coincidence" regarding both the virus and the shots.

Pfizer (PFE) and other COVID shot makers such as Moderna (MRNA) will face investor scrutiny as FDA's top vaccine regulator Dr ...

In his resignation letter, Marks wrote that health secretary Robert F. Kennedy Jr. wanted "subservient confirmation of his ...